Oral Presentation: Engineering Oral Nanomedicines for the Treatment of Parasitic Diseases

INIS

• solids 100%
• engineering 100%
• parasitic diseases 100%
• drug delivery 100%
• size 28%
• loading 28%
• in vitro 28%
• nanoparticles 28%
• plasma 28%
• capsules 28%
• biological availability 28%
• oral administration 28%
• glycols 28%
• levels 14%
• cost 14%
• stability 14%
• range 14%
• drugs 14%
• therapy 14%
• hydrogen 14%
• dissolution 14%
• testing 14%
• scanning electron microscopy 14%
• capacity 14%
• bonding 14%
• porous materials 14%
• delivery 14%
• sodium 14%
• humidity 14%
• mice 14%
• malaria 14%
• dispersions 14%
• toxicity 14%
• adsorption 14%
• mixing 14%
• solubility 14%
• suspensions 14%
• particle size 14%
• carbonyls 14%
• centrifugation 14%
• encapsulation 14%
• hplc 14%
• phase diagrams 14%
• hydroxides 14%
• lactose 14%
• quinine 14%
• lyophilization 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Parasitosis 100%
• Nanomedicine 100%
• Buparvaquone 100%
• Drug Delivery System 53%
• Excipient 15%
• Tablet 15%
• Chitosan 15%
• Nanoparticle 15%
• Bioavailability 15%
• Visceral Leishmaniasis 15%
• Scanning Electron Microscopy 7%
• Antiparasitic Agent 7%
• Reverse Phase High Performance Liquid Chromatography 7%
• Differential Scanning Calorimetry 7%
• Zeta Potential 7%
• Cytotoxicity 7%
• Antiprotozoal Agent 7%
• Leishmaniasis 7%
• Lactose 7%
• Hydroxyl Group 7%
• Carbonyl Derivative 7%
• Croscarmellose Sodium 7%
• Promastigote 7%
• Labrasol 7%